Anxiety prevalence by sex

NCS-R data put women's past-year prevalence of any anxiety disorder at roughly 23 percent versus roughly 14 percent for men, a ratio of about 1.7 to 1. The ratio is largest for specific phobia and generalized anxiety disorder, where it approaches 2 to 3 to 1 in some samples. It is smaller for OCD and social anxiety, and roughly equal for OCD. The pattern is consistent across US and international samples, including WHO World Mental Health Surveys covering 17 countries (Seedat et al., 2009).

Sex differences in anxiety are minimal in early childhood, emerge in the pre-pubertal-to-pubertal transition (roughly age 6-11 depending on the anxiety subtype), and persist across adulthood. The developmental timing points to a mix of biological and social contributors: hormonal shifts occur in the same window as changes in social expectations, peer dynamics, and, unfortunately, differential exposure to trauma.

Biological candidates include estrogen and progesterone cycling effects on stress response, HPA-axis differences, and sex-specific brain-development trajectories. The evidence for each is moderate; none accounts for the gap alone. Social candidates include differential rates of interpersonal trauma (women have higher rates of sexual assault, which is a risk factor for anxiety and PTSD), differential caregiving and financial stressors, and gender-socialization patterns around expressing distress. Measurement candidates include reporting differences (men may be less likely to endorse anxiety-related items) and stigma differences (help-seeking is more socially costly for men in some contexts). Most researchers argue that all three families of explanations contribute.

Higher prevalence does not mean anxiety is a women's illness. The disorder-level gap is real, but a large share of men also meet criteria for anxiety disorders and receive less care than the base rates would predict. Cross-cultural work shows the female-higher pattern is robust but its size varies, which suggests social context contributes even when biological factors are present.

Across national surveys, women have roughly twice the past-year prevalence of most anxiety disorders compared with men. The pattern is consistent across generalized anxiety disorder, panic disorder, specific phobia, and social anxiety disorder, and it appears in both US and international data. NIMH figures drawing on the National Comorbidity Survey Replication show this roughly two-to-one ratio for any anxiety disorder. Kessler and colleagues' NCS-R analyses documented the sex gap emerging in early adolescence, before puberty in the classical sense but around the time of pubertal transition.

Researchers have proposed several contributing explanations, and the honest summary is that no single one fully accounts for the gap. McLean and colleagues' 2011 review synthesized the candidates. Biological factors, including hormonal influences (particularly estrogen and progesterone cycling, and post-partum shifts) and HPA-axis differences, have been studied and have moderate support. Social factors, including differences in exposure to certain stressors and trauma rates, add explanatory weight. Measurement itself may play a part, because men may be less likely to report anxiety symptoms or to seek care for them, which would widen the apparent gap but does not by itself explain its magnitude.

The sex difference also interacts with treatment. Because women are diagnosed more often, they're also more often represented in treatment settings and in the clinical trials that shape the evidence base. Clinical trials of anxiety treatments have historically been more female-heavy, which means treatment recommendations are anchored to samples in which women are the majority.

The two-to-one ratio is a robust, repeatedly replicated finding. The explanation for it isn't settled, and differences in how men and women report distress may inflate the measured gap.

The ratio applies to disorder-level prevalence; subclinical anxiety symptoms show smaller sex differences.